Expression of β-catenin, E-cadherin and APC in canine mammary tumors

Anticancer Research

Volumn 27, Issue 5 A, 2007, Pages 3083-3089

  Restucci, Brunella ^a   Maiolino, Paola ^a   Martano, Manuela ^a   Esposito, Giuseppe ^a   De Filippis, Daniele ^a   Borzacchiello, Giuseppe ^a   Lo Muzio, Lorenzo ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Adhesion molecules; APC; Breast; Cadherin; Carcinogenesis; Catenin; Dog

Indexed keywords

APC PROTEIN; BETA CATENIN; UVOMORULIN; WNT1 PROTEIN;

ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST TUMOR; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HISTOLOGY; IMMUNOFLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ADENOCARCINOMA; ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; BETA CATENIN; BLOTTING, WESTERN; CADHERINS; DOG DISEASES; DOGS; FLUORESCENT ANTIBODY TECHNIQUE; MAMMARY NEOPLASMS, ANIMAL; MICROSCOPY, CONFOCAL;

EID: 35348938525     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Takeichi M: Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251: 1451-1455, 1991.
2. Takeichi M: The Cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development 102: 639-655, 1988.
3. Smith ME and Pignatelli M: The molecular histology of neoplasia: the role of the cadherin/catenin complex. Histopathology 31: 107-111, 1997.
4. Krishnadath KK, Tilanus HW, van Blankenstein M, Hop WC, Kremers ED, Dinjens WN and Bosman FT: Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis. J Pathol 182: 331-338, 1997.
5. McEntee MF and Brenneman KA: Dysregulation of beta-catenin is common in canine sporadic colorectal tumors. Vet Pathol 36: 228-236, 1999.
6. Droufakou S, Deshmane V, Roylance R, Hanby A, Tomlinson I and Hart IR: Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast. Int J Cancer 92: 404-408, 2001.
7. Roylance R, Droufakou S, Gorman P, Gillett C, Hart IR, Hanby A and Tomlinson I: The role of E-cadherin in low-grade ductal breast tumourigenesis. J Pathol 200: 53-58, 2003.
8. Sekine S, Shibata T, Matsuno Y, Maeshima A, Ishii G, Sakamoto M and Hirohashi S: β-Catenin mutations in pulmonary blastomas: association with morale formation. J Pathol 200: 214-221, 2003.
9. Kashiwaba M, Tamura G and Ishida M: Aberrations of the APC gene in primary breast carcinoma. J Cancer Res Clin Oncol 120: 727-731, 1994.
10. Medeiros AC, Nagai MA, Neto MM and Brentani RR: Loss of heterozygosity affecting the APC and MCC genetic loci in patients with primary breast carcinomas. Cancer Epidemiol Biomarkers Prev 3: 331-333, 1994.
11. El-Bahrawy MA, Talbot IC, Poulsom R, Jeffery R and Alison MR: The expression of E-cadherin and catenins in colorectal tumours from familial adenomatous polyposis patients. J Pathol 198: 69-76, 2002.
12. Abutaily AS, Collins JE and Roche WR: Cadherins, catenins and APC in pleural malignant mesothelioma. J Pathol 201: 355-362, 2003.
13. Tsuchiya T, Tamura G, Sato K, Endoh Y, Sakata K, Jin Z, Motoyama T, Usuba O, Kimura W, Nishizuka S, Wilson KT, James SP, Yin J, Fleisher AS, Zou T, Silverberg SG, Kong D and Meltzer SJ: Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia. Oncogene 19: 3642-3646, 2000.
14. Jin Z, Tamura G, Tsuchiya T, Sakata K, Kashiwaba M, Osakabe M and Motoyama T: Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers. Br J Cancer 85: 69-73, 2001.
15. Zeng L, Fagotto F, Zhang T, Hsu W, Vasicek TJ, Perry WL 3rd, Lee JJ, Tilghman SM, Gumbiner BM and Costantini F: The mouse fused locus encodes axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 90: 181-192, 1997.
16. Munemitsu S, Albert I, Souza B, Rubinfeld B and Polakis P: Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci USA 92: 3046-3050, 1995.
17. Peifer M: Beta-catenin as oncogene: the smoking gun. Science 275: 1752-1753, 1997.
18. Nusse R, van Ooyen A, Cox D, Fung YK and Varmus H: Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15. Nature 307: 131-136, 1984.
19. Polakis P: Wnt signaling and cancer. Genes Dev 14: 1837-1851, 2000.
20. Bienz M and Clevers H: Linking colorectal cancer to Wnt signaling. Cell 103: 311-320, 2000.
21. Misdorp W, Else RW, Hellmèn E and Lipscomb TP: Histological classification of mammary tumors of the dog and the cat: Bulletin of The World Health Organization, International Histological Classification of Tumors of Domestic Animals, vol. VII. Washington, DC USA, pp. 18-25, 1999.
22. Misdorp W: Histologic classification and further characterization of tumours in domestic animals. Adv Vet Sci Comp Med 20: 191-221, 1976.
23. Borzacchiello G, Ambrosio V, Galati P, Perillo A and Roperto F: Cyclooxygenase-1 and -2 expression in urothelial carcinomas of the urinary bladder in cows. Vet Pathol 40: 455-459, 2003.
24. Izzo AA, Fezza F, Capasso R, Bisogno T, Pinto L, Iuvone T, Esposito G, Mascolo N, Di Marzo V and Capasso F: Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation. Br J Pharmacol 134: 563-570, 2001.
25. Pignatelli M: E-cadherin: a biological marker of tumour differentiation. J Pathol 171: 81-82, 1993.
26. Gamallo C, Palacios J, Suarez A, Pizarro A, Navarro P, Quintanilla M and Cano A: Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 142: 987-993, 1993.
27. Restucci B, Papparella S, De Vico G and Maiolino P: E Cadherin expression in normal and neoplastic canine mammary gland. J Comp Pathol 116: 191-202, 1997.
28. Sarli G, Preziosi R, De Tolla L, Brunetti B and Benazzi C: E-cadherin immunoreactivity in canine mammary tumors. J Vet Diagn Invest 16: 542-547, 2004.
29. Gumbiner BM: Carcinogenesis: a balance between beta-catenin and APC. Curr Biol 7: R443-446, 1997.
30. Ilyas M and Tomlinson IP: The interactions of APC, E-cadherin and beta-catenin in tumour development and progression. J Pathol 182: 128-137, 1997.
31. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B and Clevers H: Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275: 1784-1787, 1997.
32. Korinek V, Barker N, Moerer P, van Donselaar E, Huls G, Peters PJ and Clevers H: Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet 19: 379-383, 1998.
33. Morin PJ: beta-catenin signaling and cancer. Bioessays 21: 1021-1030, 1999.
34. Tetsu O and McCormick F: Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422-426, 1999.
35. Nagafuchi A and Takeichi M: Cell binding function of E-cadherin is regulated by the cytoplasmic domain. Embo J 7: 3679-3684, 1988.
36. De Wever O and Mareel M: Role of tissue stroma in cancer cell invasion. J Pathol 200: 429-447, 2003.
37. Sternlicht MD, Kedeshian P, Shao ZM, Safarians S and Barsky SH: The human myoepithelial cell is a natural tumor suppressor. Clin Cancer Res 3: 1949-1958, 1997.
38. Sternlicht MD and Barsky SH: The myoepithelial defense: a host defense against cancer. Med Hypotheses 48: 37-46, 1997.
39. Cardiff RD, Sinn E, Muller W and Leder P: Transgenic oncogene mice. Tumor phenotype predicts genotype. Am J Pathol 139: 495-501, 1991.
40. Rosner A, Miyoshi K, Landesman-Bollag E, Xu X, Seldin DC, Moser AR, MacLeod CL, Shyamala G, Gillgrass AE and Cardiff RD: Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors. Am J Pathol 161: 1087-1097, 2002.
41. Michaelson JS and Leder P: Beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland. Oncogene 20: 5093-5099, 2001.
42. Chen G, Shukeir N, Potti A, Sircar K, Aprikian A, Goltzman D and Rabbani SA: Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications. Cancer 101: 1345-1356, 2004.
43. Dihlmann S and von Knebel Doeberitz M: Wnt/beta-catenin-pathway as a molecular target for future anti-cancer therapeutics. Int J Cancer 113: 515-524, 2005.